Sort
48,018 grants matching “immunotherapy”
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
$591,712Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2018 · GM
Research Training in Academic Medical Oncology
$591,629Michael Davies · University Of Tx Md Anderson Can Ctr · T32 · FY2022 · CA
Dendritic Cell mediated induction of Anti-HCV immunity
$591,583New York University School Of Medicine · R01 · FY2005 · AI
Role of the Innate Immune System in the Survival of Auditory Neurons
$591,548Mark E. Warchol · Washington University · R01 · FY2021 · DC
Role of the Innate Immune System in the Survival of Auditory Neurons
$591,548Mark E. Warchol · Washington University · R01 · FY2020 · DC
Role of the Innate Immune System in the Survival of Auditory Neurons
$591,548Mark E. Warchol · Washington University · R01 · FY2019 · DC
Role of the Innate Immune System in the Survival of Auditory Neurons
$591,548Mark E. Warchol · Washington University · R01 · FY2018 · DC
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$591,527Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
$591,459Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2022 · CA
Project 1: DNA Methylation-Based Blood Biomarkers for Prognosis, Molecular Stratification and Treatment Response in Glioma Patients
$591,452Annette M Molinaro · University Of California, San Francisco · P50 · FY2024 · CA
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$591,430Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Epigenetic regulation of natural killer cell memory
$591,368Colleen M. Lau · Cornell University · R01 · FY2025 · AI
Development of a translational imaging tool as a predictive biomarker for anti-PD-1/PD-L1 immunotherapies
$591,330Michael John Evans · University Of California, San Francisco · R01 · FY2020 · EB
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
$591,326Giannicola Genovese · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Uterine NK Cells in Primate Pregnancy
$591,326Thaddeus G Golos · University Of Wisconsin-Madison · R01 · FY2010 · HD
Modulation of the tumor microenvironment with probiotic therapies
$591,316Tal Danino · Columbia Univ New York Morningside · R01 · FY2020 · CA
Combating melanoma with an attenuated bacterial therapeutic
$591,249Jianxun Jim Song · Texas A&M University Health Science Ctr · R01 · FY2024 · CA
Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer
$591,227Mehmet Toner · Massachusetts General Hospital · U01 · FY2024 · CA
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$591,222Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$591,222Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis
$591,126Efstathios Karathanasis · Case Western Reserve University · R01 · FY2021 · CA
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis
$591,007Efstathios Karathanasis · Case Western Reserve University · R01 · FY2020 · CA
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish
$590,985Leanna J Standish · Bastyr University · U19 · FY2010 · AT
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis
$590,958Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2022 · CA
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
$590,812Elinor Karlsson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA